Antidote.me

About:

Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.

Website: http://www.antidote.me

Twitter/X: antidote_me

Top Investors: Octopus Ventures, Amadeus Capital Partners, Smedvig Ventures, Merck Global Health Innovation Fund, LBO France

Description:

Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK.

Total Funding Amount:

$52.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2010-01-01

Contact Email:

hello(AT)antidote.me

Founders:

Eithan Ephrati, Jessica Mann, Pablo Graiver

Number of Employees:

51-100

Last Funding Date:

2021-06-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai